Rituximab induced acute thrombocytopenia in a patient with systemic lupus erythematosus: a case report

BACKGROUND: Rituximab is a novel chimeric monoclonal antibody that has established itself as a potent therapeutic option for autoimmune medical conditions, including systemic lupus erythematosus, owing to its mechanism of action targeting CD20 cells. Rituximab is also known to cause a spectrum of si...

Descripción completa

Detalles Bibliográficos
Autores principales: Yudhishdran, Jevon, Sivakumar, Jeyalakshmy, Navinan, Mitrakrishnan Rayno, Bandapatti, Sareesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264985/
https://www.ncbi.nlm.nih.gov/pubmed/34233732
http://dx.doi.org/10.1186/s13256-021-02950-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264985/
https://www.ncbi.nlm.nih.gov/pubmed/34233732
http://dx.doi.org/10.1186/s13256-021-02950-y

Ejemplares similares